- Home
- SLXN vs GURE Comparison
SLXN vs GURE Comparison
Compare SLXN & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- GURE
- Stock Information
- Founded
- SLXN 2008
- GURE 2006
- Country
- SLXN Israel
- GURE China
- Employees
- SLXN N/A
- GURE N/A
- Industry
- SLXN
- GURE Major Chemicals
- Sector
- SLXN
- GURE Industrials
- Exchange
- SLXN NYSE
- GURE Nasdaq
- Market Cap
- SLXN 4.3M
- GURE 7.1M
- IPO Year
- SLXN N/A
- GURE 1992
- Fundamental
- Price
- SLXN $1.08
- GURE $0.78
- Analyst Decision
- SLXN Strong Buy
- GURE
- Analyst Count
- SLXN 1
- GURE 0
- Target Price
- SLXN $9.00
- GURE N/A
- AVG Volume (30 Days)
- SLXN 31.3M
- GURE 38.4K
- Earning Date
- SLXN 02-25-2025
- GURE 11-19-2024
- Dividend Yield
- SLXN N/A
- GURE N/A
- EPS Growth
- SLXN N/A
- GURE N/A
- EPS
- SLXN N/A
- GURE N/A
- Revenue
- SLXN N/A
- GURE $12,802,982.00
- Revenue This Year
- SLXN N/A
- GURE N/A
- Revenue Next Year
- SLXN N/A
- GURE N/A
- P/E Ratio
- SLXN N/A
- GURE N/A
- Revenue Growth
- SLXN N/A
- GURE N/A
- 52 Week Low
- SLXN $0.21
- GURE $0.50
- 52 Week High
- SLXN $13.56
- GURE $1.79
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- GURE 63.71
- Support Level
- SLXN N/A
- GURE $0.61
- Resistance Level
- SLXN N/A
- GURE $0.73
- Average True Range (ATR)
- SLXN 0.00
- GURE 0.07
- MACD
- SLXN 0.00
- GURE 0.01
- Stochastic Oscillator
- SLXN 0.00
- GURE 98.82
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.